TXMD
TherapeuticsMD, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$2.20
−1.79%Aug 11, 2026, 20:01 UTC
TherapeuticsMD announced its second quarter 2026 financial results, reporting net income from continuing operations of $164 thousand and license revenue of $864 thousand.